Pd71-06 CTC-Based Gene Expression for Predicting Resistance to Abiraterone and Enzalutamide in McRPC

Journal of Urology - Netherlands
doi 10.1016/j.juro.2017.02.3173
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Simultaneous Quantitation of Abiraterone, Enzalutamide, N -Desmethyl Enzalutamide, and Bicalutamide in Human Plasma by LC–MS/MS

Journal of Pharmaceutical and Biomedical Analysis
Clinical BiochemistryDrug DiscoveryAnalytical ChemistrySpectroscopyPharmaceutical Science
2017English

Improved Androgen Receptor Splice Variant 7 Detection Using a Highly Sensitive Assay to Predict Resistance to Abiraterone or Enzalutamide in Metastatic Prostate Cancer Patients

European urology oncology
OncologyRadiologyUrologyNuclear MedicineImagingSurgery
2019English

Mp87-03 Targeted Gene Expression Profiling Within Circulating Tumor Cells in McRPC

Journal of Urology
Urology
2018English

Enzalutamide and Abiraterone in the Treatment of Metastatic Castration-Resistant Prostate Cancer After Chemotherapy

Klinicka Onkologie
Oncology
2016English

Germline Variant in SLCO2B1 and Response to Abiraterone Acetate Plus Prednisone (AA) in New Onset Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer

Clinical Cancer Research
Cancer ResearchOncology
2018English

Taking Into Account Nucleosomes for Predicting Gene Expression

Methods
BiochemistryGeneticsMolecular Biology
2013English

The Lack of a Relationship Between Physician Payments From Drug Manufacturers and Medicare Claims for Abiraterone and Enzalutamide

Cancer
Cancer ResearchOncology
2017English

Predicting Biomarkers for Ovarian Cancer Using Gene-Expression Microarrays

British Journal of Cancer
Cancer ResearchOncology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy